Literature DB >> 17079258

Eotaxin-2 in sputum cell culture to evaluate asthma inflammation.

M E Scheicher1, M M Teixeira, F Q Cunha, A L Teixeira, J T Filho, E O Vianna.   

Abstract

The aim of the present study was to elucidate whether the culture of cells recovered from induced sputum may represent a suitable model to evaluate cytokine and chemokine production by airway inflammatory cells. Sputum induction was performed in 21 normal subjects and 30 asthmatic patients. A total of 21 out of the 30 asthmatic patients were taking inhaled corticosteroids, while the remaining nine were steroid-naive asthmatics. The steroid-naive group was evaluated before and after a 14-day treatment with oral prednisone (40 mg.day(-1)). The supernatant of lysed and centrifuged sputum and the supernatant of sputum cell culture were analysed. Tumour necrosis factor-alpha, interleukin (IL)-8 (CXCL8), IL-1beta, IL-13 and eotaxin-2 (CCL24) concentrations were determined by specific ELISA. Eotaxin-2 production by cell culture was higher in the asthma group (131+/-108 pg.mL(-1)) than in the control group (36+/-41 pg.mL(-1)) and treatment with oral corticosteroids eliminated this difference. In addition, reduction of eotaxin-2 levels by corticosteroid treatment was greater in cell culture (81.3% reduction) than in sputum (26.4%). There was correlation between the decrease in eotaxin-2 production and the decrease in blood eosinophil number and between eotaxin-2 and eosinophils in sputum. Eotaxin-2 may play an important role in asthma and the response to corticosteroid treatment suggests that analysis of sputum cell culture is relevant as an inflammatory parameter.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17079258     DOI: 10.1183/09031936.00060205

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

1.  The roles of a Th2 cytokine and CC chemokine in children with stable asthma: potential implication in eosinophil degranulation.

Authors:  Chang K Kim; Hirohito Kita; Zak Callaway; Hyo B Kim; Jungi Choi; Takao Fujisawa; Bo M Shin; Young Y Koh
Journal:  Pediatr Allergy Immunol       Date:  2010-04-27       Impact factor: 6.377

2.  Epithelial eotaxin-2 and eotaxin-3 expression: relation to asthma severity, luminal eosinophilia and age at onset.

Authors:  John M Coleman; Chetan Naik; Fernando Holguin; Anuradha Ray; Prabir Ray; John B Trudeau; Sally E Wenzel
Journal:  Thorax       Date:  2012-09-26       Impact factor: 9.139

3.  Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.

Authors:  Timothy J Bensman; Jordanna G Jayne; Meiling Sun; Elza Kimura; Joshua Meinert; Joshua C Wang; Justin B Schaal; Dat Tran; Adupa P Rao; Omid Akbari; Michael E Selsted; Paul M Beringer
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

4.  Protein microarray analysis in patients with asthma: elevation of the chemokine PARC/CCL18 in sputum.

Authors:  Hyo-Bin Kim; Chang-Keun Kim; Koji Iijima; Takao Kobayashi; Hirohito Kita
Journal:  Chest       Date:  2008-11-18       Impact factor: 9.410

Review 5.  Effects of prednisone on eosinophilic bronchitis in asthma: a systematic review and meta-analysis.

Authors:  Thiago Mamôru Sakae; Rosemeri Maurici; Daisson José Trevisol; Marcia Margaret Menezes Pizzichini; Emílio Pizzichini
Journal:  J Bras Pneumol       Date:  2014-10       Impact factor: 2.624

6.  Regulation of Eosinophil and Group 2 Innate Lymphoid Cell Trafficking in Asthma.

Authors:  Marie-Chantal Larose; Anne-Sophie Archambault; Véronique Provost; Michel Laviolette; Nicolas Flamand
Journal:  Front Med (Lausanne)       Date:  2017-08-11

Review 7.  Deciphering Asthma Biomarkers with Protein Profiling Technology.

Authors:  Zhizhou Kuang; Jarad J Wilson; Shuhong Luo; Si-Wei Zhu; Ruo-Pan Huang
Journal:  Int J Inflam       Date:  2015-08-06

8.  Metabolic disease risk in children by salivary biomarker analysis.

Authors:  J Max Goodson; Alpdogan Kantarci; Mor-Li Hartman; Gerald V Denis; Danielle Stephens; Hatice Hasturk; Tina Yaskell; Jorel Vargas; Xiaoshan Wang; Maryann Cugini; Roula Barake; Osama Alsmadi; Sabiha Al-Mutawa; Jitendra Ariga; Pramod Soparkar; Jawad Behbehani; Kazem Behbehani; Francine Welty
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.